Skip to main content

Advertisement

Log in

Prevention of low bone mass to achieve high bone density in Mexico: position of the Mexican Association for Bone and Mineral Metabolism

  • Position Paper
  • Published:
Archives of Osteoporosis Aims and scope Submit manuscript

Abstract

Summary

In Mexico, osteoporosis is a public health problem. In this document, the Mexican Association for Bone and Mineral Metabolism defines its position on calcium, vitamin D supplement use, and physical activity as an effective, safe, and cost-effective initiatives to prevent low bone mass.

Introduction

In Mexico, osteoporosis is a public health problem that is expected to increase in the decades ahead. Generally, modifiable risk factors for bone health are related with lifestyles, especially nutrition and physical activity.

Methods

In this position paper, the Mexican Association for Bone and Mineral Metabolism (AMMOM, by its acronym in Spanish), which is a multidisciplinary group of researchers, dietitians, epidemiologists, nurses, and physicians who study bone and related tissues and communicate the best strategies for diagnosis, treatment, and prevention of bone problems, aims to analyze the association between nutrition and bone health, risk behaviors for low bone mass, and the economic impact that prevention of low bone mass represents for the health care system.

Results

Addressing therapeutic management with pharmacological and non-pharmacological approaches, we emphasize the important role the patient plays in the doctor–patient relationship, both in the consulting room and in daily life. Furthermore, the AMMOM defines its position on calcium and vitamin D supplement use as an effective, safe, and cost-effective initiative to prevent low bone mass.

Conclusions

In summary, most research and clinical practice related to osteoporosis have focused on diagnosis and treatment, but general measures for primary prevention based on addressing modifiable risk factors as a public health priority to delay the onset of loss of bone mass have not been considered by Mexican authorities. Consequently, the AMMOM task force also seeks to provide information on concrete actions to prevent low bone mass.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kanis JA, McCloskey EV, Johansson H et al (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57

    Article  CAS  PubMed  Google Scholar 

  2. Clark P, Lavielle P, Franco-Marina F, Ramírez E, Salmerón J, Kanis JA, Cummings SR (2005) Incidence rates and life-time risk of hip fractures in Mexicans over 50 years of age: a population-based study. Osteoporos Int 16:2025–2030

    Article  PubMed  Google Scholar 

  3. Clark P, Cons-Molina F, Deleze M, Ragi S, Haddock L, Zanchetta JR, Jaller JJ, Palermo L, Talavera JO, Messina DO, Morales-Torres J, Salmeron J, Navarrete A, Suarez E, Pérez CM, Cummings SR (2009) The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS). Osteoporos Int 20:275–282

    Article  CAS  PubMed  Google Scholar 

  4. Carlos F, Clark P, Galindo-Suárez RM, Chico-Barba LG (2013) Health care costs of osteopenia, osteoporosis, and fragility. Arch Osteoporos 8:125. https://doi.org/10.1007/s11657-013-0125-4

    Article  PubMed  Google Scholar 

  5. Gennari C (2001) Calcium and vitamin D nutrition and bone disease of the elderly. Public Health Nutr 4:547–559

    Article  CAS  PubMed  Google Scholar 

  6. North American Menopause Society (2006) The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society. Menopause 13:862–877

    Article  Google Scholar 

  7. Food and Agriculture Organization (2013) Dairy production and products. Milk and milk products. www.fao.org/dairy-production-products/products/en/. Accessed 20 Jan 2018)

  8. Rivera-Dommarco J, López-Olmedo N, Aburto-Soto T et al (2014) Consumo de productos lácteos en población Mexicana. Resultados de la Encuesta Nacional de Salud y Nutrición 2012. Instituto Nacional de Salud Pública, México

    Google Scholar 

  9. Heaney RP (2008) Vitamin D and calcium interactions: functional outcomes. Am J Clin Nutr 88:541S–544S

    Article  CAS  PubMed  Google Scholar 

  10. Contreras-Manzano A, Villalpando S, Robledo-Pérez R (2017) Vitamin D status by sociodemographic factors and body mass index in Mexican women at reproductive age. Salud Publica Mex 59:518–525

    Article  PubMed  Google Scholar 

  11. Denova-Gutiérrez E, Clark P, Muñoz-Aguirre P et al (2016) Dietary patterns are associated with calcium and vitamin D intake in an adult Mexican population. Nutr Hosp 33:276. https://doi.org/10.20960/nh.276

    Article  PubMed  Google Scholar 

  12. Institute of Medicine (2011) Dietary reference intakes for calcium and vitamin D. The National Academies Press (US), Washington, DC

    Google Scholar 

  13. Sánchez-Pimienta TG, López-Olmedo N, Rodríguez-Ramírez S et al (2016) High prevalence of inadequate calcium and iron intakes by Mexican population groups as assessed by 24-hour recalls. J Nutr 146:1874S–1880S

    Article  PubMed  CAS  Google Scholar 

  14. Pedroza-Tobías A, Hernández-Barrera L, López-Olmedo N, et al (2016) Usual vitamin intakes by Mexican populations. J Nutr 146:1866S–1873S

    Article  PubMed  CAS  Google Scholar 

  15. Rizzoli R, Bianchi ML, Garabedian M et al (2010) Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly. Bone 46:294–305

    Article  PubMed  Google Scholar 

  16. Cheng S, Lyytikainen A, Kroger H et al (2005) Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: a 2-y randomized trial. Am J Clin Nutr 82:1115–1126

    Article  CAS  PubMed  Google Scholar 

  17. Esterle L, Sabatier JP, Guillon-Metz F, Walrant-Debray O, Guaydier-Souquières G, Jehan F, Garabédian M (2009) Milk, rather than other foods, is associated with vertebral bone mass and circulating IGF-1 in female adolescents. Osteoporos Int 20:567–575

    Article  CAS  PubMed  Google Scholar 

  18. Manios Y, Moschonis G, Trovas G, et al (2007) Changes in biochemical indexes of bone metabolism and bone mineral density after a 12-mo dietary intervention program: the Postmenopausal Health Study. Am J Clin Nutr 86:781–789

    Article  CAS  PubMed  Google Scholar 

  19. Bonjour JP, Benoit V, Pourchaire O, et al (2009) Inhibition of markers of bone resorption by consumption of vitamin D and calcium-fortified soft plain cheese by institutionalised elderly women. Br J Nutr 102:962–966

    Article  CAS  PubMed  Google Scholar 

  20. Denova-Gutierrez E, Clark P, Tucker KL, et al (2016) Dietary patterns are associated with bone mineral density in an urban Mexican adult population. Osteoporos Int 27:3033–3040

    Article  PubMed  CAS  Google Scholar 

  21. Winzenberg TM, Shaw K, Fryer J, et al (2006) Calcium supplementation for improving bone mineral density in children. Cochrane Database Syst Rev 2:CD005119

  22. Avenell A, Mak JC, O'Connell D (2014) Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 4:CD000227

  23. Shea B, Wells G, Cranney A, et al (2004) Calcium supplementation on bone loss in postmenopausal women. Cochrane Database Syst Rev 1:CD004526

  24. Osteoporosis. Clinical guideline for prevention and treatment. Executive Summary. National Osteoporosis Guideline Group (NOGG) on behalf of the Bone Research Society, British Geriatrics Society, British Orthopaedic Association, British Society of Rheumatology, National Osteoporosis Society, Osteoporosis 2000, Osteoporosis Dorset, Primary Care Rheumatology Society, Royal College of Physicians and Society for Endocrinology. 2010

  25. Wadsworth TG (1990) Colles’ fracture: failure in management may cause permanent disability. BMJ 301:192–194

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Ross PD, He YF, Yates AJ, et al (1994) Body size accounts for most differences in bone density between Asian and Afro-Caribbean women. Clin Sci 87:339–343

  27. Tobias JH, Cook DG, Chambers TJ, et al. A comparison of bone mineral density between Caucasian, Asian and Afro-Caribbean women. Clin Sci 1994;87(5):587–591

    Article  CAS  PubMed  Google Scholar 

  28. The DIPART (vitamin D Individual Patient Analysis of Randomized Trials) Group (2010) Patient level pooled analysis of 68500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 340:b5463. https://doi.org/10.1136/bmj.b5463

  29. Wang L, Manson JE, Sesso HD (2012) Calcium Intake and Risk of Cardiovascular Disease: A Review of Prospective Studies and Randomized Clinical Trials. American Journal of Cardiovascular Drugs12:105–116. https://doi.org/10.2165/11595400-000000000-00000

    Article  CAS  Google Scholar 

  30. Chung M, Tang AM, Fu Z, et al (2016) Calcium intake and cardiovascular disease risk. An updated systematic review and meta-analysis. Ann Intern Med 165:856–866

    Article  PubMed  Google Scholar 

  31. Margolis KL, Manson JE (2016) Calcium supplements and cardiovascular disease risk: What do clinicians and patients need to know? Ann Intern Med 165:884-885

    Article  PubMed  Google Scholar 

  32. Russell-Aulet, Wang J (1993) Bone mineral density and mass in a crossectional study of white and asian women, J Bone Miner Res 8:575–582

    Article  Google Scholar 

  33. Hodgson SF, Watts NB, Bilezikian JP (2003) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.Endoc Pract 9:544–564

  34. Mykkanen HM, Wasserman RH (1983) Enhanced absorption of calcium by casein phosphopeptides in rachitic a normal chick. J Nutr 110:2141–2148

    Article  PubMed  Google Scholar 

  35. Recker RR, Bammi A, Barger-Lux MJ, et al (1988) Calcium absorbability from milk products, and imitation milk, and calcium carbonate. Am J Clin Nutr 47:93–95

    Article  CAS  PubMed  Google Scholar 

  36. Rosado JL (2016) Lactose Intolerance. Gac Med Mex 152(Suppl 1):67-73

  37. Heine RG, AlRefaee F, Bachina P, et al (2017) Lactose intolerance and gastrointestinal cow's milk allergy in infants and children - common misconceptions revisited.World Allergy Organ J10:41. https://doi.org/10.1186/s40413-017-0173-0

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  38. Shea B, Wells G, Cranney A, et al (2002) Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 23:552–559

    Article  CAS  PubMed  Google Scholar 

  39. Aguilera-Barreiro MA, Guerrero-Mercado AS, Méndez-Jiménez TE, et al (2005) Efecto del calcio dietético vs el citrato de calcio sobre marcadores bioquímicos convencionales, en mujeres perimenopáusicas. Salud Publica Mex 47:259–267

    Article  Google Scholar 

  40. Mavroeidi A, Stewart AD, Reid DM, et al (2009) Physical activity and dietary calcium interactions in bone mass in Scottish postmenopausal women. Osteoporos Int 20:409–416

    Article  PubMed  CAS  Google Scholar 

  41. Yoon SJ, Lee MJ, Lee HM, et al (2016) Effect of low-intensity resistance training with heat stress on the HSP72, anabolic hormones, muscle size, and strength in elderly women.Aging Clin Exp Res 29:977–984

    Article  PubMed  Google Scholar 

  42. Pham HM, Nguyen ND, Center JR, et al (2016)Contribution of Quadriceps Weakness to Fragility Fracture: A Prospective Study. J Bone Miner Res 31:208–214

    Article  PubMed  Google Scholar 

  43. Lombardi G, Sanchis-Gomar F, Perego S (2016)Implications of exercise-induced adipo-myokines in bone metabolism. Endocrine 54:284–305

    Article  PubMed  CAS  Google Scholar 

  44. Martyn-St James M, Carroll S(2010)Effects of different impact exercise modalities on bone mineral density in premenopausal women: a meta-analysis.  J Bone Miner Metab28:251–267

    Article  PubMed  Google Scholar 

  45. Smith EN, Boser A (2013) Yoga, vertebral fractures, and osteoporosis: research and recommendations. Int J Yoga Therap 23:17–23

  46. Tüzün S, Aktas I, Akarirmak U, et al (2010)Yoga might be an alternative training for the quality of life and balance in postmenopausal osteoporosis.Eur J Phys Rehabil Med 46:69–72

  47. Fielding RA, Vellas B, Evans WJ, et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and conse- quences. International working group on sarcopenia. J Am Med Dir Assoc 12:249–256

    Article  PubMed  Google Scholar 

  48. Espinel-Bermúdez MC, Sánchez-García S, García-Peña C, et al (2018) Associated factors with sarcopenia among Mexican elderly: 2012 National Health and Nutrition Survey. Rev Med Inst Mex Seguro Soc56(Suppl 1):S46–S53

  49. Olsen CF, Bergland A (2014) The effect of exercise and education on fear of falling in elderly women with osteoporosis and a history of vertebral fracture: results of a randomized controlled trial.Osteoporos Int 25:2017–2025

    Article  CAS  PubMed  Google Scholar 

  50. Stalmeier PF (2011) Adherence and decision AIDS: a model and a narrative review. Med Decis Making 31:121–129

    Article  PubMed  Google Scholar 

  51. Hill L, Mueller M, Roussos S, et al (2009) Opportunities for the use decision aids in primary care. Fam Med 41:350–355

Download references

Contributors

All the authors were involved in the conceptual design of the manuscript. RE, PC, EDG, MAAB, MF, PD, SJ, MPPR, FS, PL, and VM prepared a section of the first version of the manuscript. EDG reviewed and edited the first version of the manuscript. All the authors reviewed and approved the final version of the manuscript.

Funding

This paper was supported by Pfizer Mexico, SA de CV, which allowed the experts’ meetings. All the authors received an honorarium from Pfizer in connection with the development of this manuscript.

Medical writing support was provided by Dr. Karim Majluf Cruz at ByronMuller and was funded by Pfizer.

Editorial support was provided by Dr. Edgar Denova and was funded by Pfizer.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edgar Denova-Gutiérrez.

Ethics declarations

Conflicts of interest

None.

Statement of human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study, informed consent is not required.

Electronic supplementary material

ESM 1

(DOCX 36 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Espinosa, R., Clark, P., Denova-Gutiérrez, E. et al. Prevention of low bone mass to achieve high bone density in Mexico: position of the Mexican Association for Bone and Mineral Metabolism. Arch Osteoporos 13, 105 (2018). https://doi.org/10.1007/s11657-018-0520-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11657-018-0520-y

Keywords

Navigation